Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: BCC Research | PRODUCT CODE: 2087984

Cover Image

PUBLISHER: BCC Research | PRODUCT CODE: 2087984

Cardiovascular Devices: Global Markets to 2030

PUBLISHED:
PAGES: 170 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4650
PDF & Excel (2-5 Users)
USD 5580
PDF & Excel (Site License)
USD 6696
PDF & Excel (Enterprise License)
USD 8035

Add to Cart

The global market for cardiovascular devices is expected to grow from $72.4 billion in 2025 and is projected to reach $101.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.0% during the forecast period of 2025 to 2030.

Report Scope

The report provides an overview of the global cardiovascular devices market and analyzes market trends. It includes global revenue ($ million) using 2024 as the base year, estimated data for 2025, and projected data for 2026 through 2030.

The market is segmented by product and end user. Based on product, the cardiovascular devices market is segmented into interventional cardiology, cardiac rhythm management, diagnostics and monitoring, cardiac assist devices, electrophysiology, and other vascular surgery devices. Based on end users, the market is segmented into hospitals and clinics, ambulatory surgical centers, diagnostic laboratories, and other end users. Geographical regions covered in this study are North America (the U.S., Canada, and Mexico), Europe (Germany, the U.K., Italy, France, Spain, and the rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia-Pacific), the Middle East and Africa (MEA), and South America, focusing on all the major countries in these regions.

The report focuses on the key driving trends and challenges shaping the market and vendor landscape. It analyzes and discusses emerging technologies related to the market.

The report concludes by analyzing the competitive landscape and providing the leading global cardiovascular devices companies. It also includes a dedicated section of company profiles that covers overviews, key financials, product portfolios, and recent developments for major companies.

Report Includes

  • 69 data tables and 73 additional tables
  • An overview and analysis of the global cardiovascular devices market
  • Analyses of global market trends, with revenue data for 2022-2025, and projections of CAGRs through 2030
  • Estimates of the current market size and future revenue growth prospects, accompanied by a market share analysis by product, end user, and region
  • Facts and figures pertaining to market dynamics, including key drivers, restraints, opportunities, challenges, and the impact of macroeconomic factors
  • Review of regulatory frameworks across major regions, along with an assessment of approval pathways and compliance requirements
  • Insights into emerging technologies and developments, including innovations in minimally invasive devices, remote patient monitoring, and implantable cardiovascular technologies
  • Patent analysis highlighting key granted and published patents related to cardiovascular medical devices
  • Analysis of the competitive landscape, including company market share rankings, strategic initiatives, partnerships, and recent developments
  • Overview of sustainability trends and ESG developments in the global cardiovascular devices market
  • Profiles of the leading global companies, including Medtronic, Abbott, Boston Scientific Corp., Edwards Lifesciences Corp., and Johnson & Johnson
Product Code: HLC210B

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary
  • Overview
  • Current Market Scenario
  • Segmental Analysis
  • Technological Advances
  • Conclusion

Chapter 2 Market Overview

  • Overview
  • Type of Cardiovascular Diseases
  • Coronary Artery Disease
  • Arrhythmia
  • Structural Heart Disease
  • Heart Infection
  • Cardiovascular Procedures Volume
  • Cardiovascular Procedures Cost
  • Porter's Five Forces Analysis in the Technologies for Cardiovascular Devices Market
  • Potential for New Entrants (Low to Moderate)
  • Bargaining Power of Suppliers (Moderate)
  • Bargaining Power of Buyers (Moderate)
  • Threat of Substitutes (Low)
  • Competition in the Industry (High)
  • Macroeconomic Factor Analysis
  • Urbanization and Lifestyle Changes
  • Shortage of Skilled Professionals
  • U.S. Tariff Scenario

Chapter 3 Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Rising Prevalence of Cardiovascular Disorders and Other Lifestyle-Related Disorders
  • Growing Demand for Minimally Invasive Procedures in Cardiovascular Treatment
  • Increasing Adoption of Remote Patient Monitoring for Cardiac Disease Management
  • Market Restraints
  • Stringent Product Approval Guidelines
  • High Cost of Advanced Cardiovascular Devices and Procedures
  • Market Opportunities
  • Growing Demand for Preventive and Early-Diagnosis Solutions
  • Increasing Focus on Value-Based Healthcare
  • Market Challenges
  • Complex Product Development
  • Complications Associated with Implantable Devices

Chapter 4 Regulatory Landscape

  • U.S.
  • Europe
  • Other Regions

Chapter 5 Emerging Technologies and Developments

  • Emerging Technologies
  • Leadless and Wireless Cardiac Implants
  • Bioresorbable Cardiac Devices
  • Wearable Cardiac Devices
  • Total Artificial Heart
  • Artificial Intelligence
  • Patent Analysis
  • Key Takeaways
  • Patents, by Year
  • By Top Applicant
  • By Top Owner
  • By Jurisdiction

Chapter 6 Market Segmentation Analysis

  • Segmentation Breakdown
  • Market Analysis by Product
  • Key Takeaways
  • Interventional Cardiology
  • Cardiac Rhythm Management
  • Diagnostics and Monitoring
  • Cardiac Assist Devices
  • Electrophysiology
  • Other Vascular Surgery Devices
  • Market Analysis by End User
  • Key Takeaways
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Diagnostics Laboratories
  • Other End Users
  • Geographic Breakdown
  • Market Analysis by Region
  • Key Takeaways
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa (MEA)

Chapter 7 Competitive Intelligence

  • Key Takeaways
  • Competitive Landscape
  • Leading Companies in the Global Cardiovascular Devices Market
  • Medtronic
  • Abbott
  • Boston Scientific Corp
  • Edward
  • Johnson & Johnson
  • Key Developments and Strategies

Chapter 8 Appendix

  • Methodology
  • Sources
  • Abbreviations
  • Company Profiles
  • ABBOTT
  • BAXTER
  • B. BRAUN SE
  • BIOTRONIK
  • BOSTON SCIENTIFIC CORP.
  • BPL MEDICAL TECHNOLOGIES
  • COOK
  • EDWARDS LIFESCIENCES CORP.
  • GE HEALTHCARE
  • JOHNSON & JOHNSON
  • KONINKLIJKE PHILIPS N.V.
  • MEDTRONIC
  • NIHON KOHDEN CORP.
  • SIEMENS HEALTHINEERS AG
  • TERUMO CORP.
  • Few Emerging Start-Ups/ Market Disruptors
Product Code: HLC210B

List of Tables

  • Summary Table : Global Market for Cardiovascular Devices, by Region, Through 2030
  • Table 1 : Cardiovascular Diseases: Modifiable Risk Factors
  • Table 2 : Global: Annual Cardiac Surgical Volumes per 100,000 Population Per Year
  • Table 3 : Cost of Cardiovascular Surgery, by Country, 2025
  • Table 4 : Porter's Five Forces Analysis: Overview
  • Table 5 : Global Cardiovascular Disease: Prevalence and Deaths, 2023
  • Table 6 : Advantages of Remote Patient Monitoring
  • Table 7 : Cardiovascular Care Programs Driving Value-Based Outcomes and Cost Efficiency
  • Table 8 : Complications Associated with Implantable Devices
  • Table 9 : FDA Regulatory Pathways and Cardiovascular Device Classification Overview
  • Table 10 : EU Medical Device Regulatory Pathway
  • Table 11 : Other Region: Cardiovascular Regulatory Landscape
  • Table 12 : List of Wearable Cardiac Devices
  • Table 13 : Total Artificial Heart, Company Comparison, 2026
  • Table 14 : AI in Cardiology: Application
  • Table 15 : Patents, by Top Applicant, 2022-2025
  • Table 16 : Patents, by Top Owner, 2022-2025
  • Table 17 : Patents, by Jurisdiction, 2022-2025
  • Table 18 : Global Market for Cardiovascular Devices Market, by Product, Through 2030
  • Table 19 : TAVR Systems, by Company
  • Table 20 : TMVR Systems, by Company
  • Table 21 : Major Catheters in Interventional Cardiology
  • Table 22 : Type of Cardiovascular Stent
  • Table 23 : Advances in Drug-Eluting Stents
  • Table 24 : Global Market for Interventional Cardiology, by Type, Through 2030
  • Table 25 : Pacemaker, by Company
  • Table 26 : Advances in Pacemakers
  • Table 27 : CRT Devices, by Company
  • Table 28 : ICD Devices, by Company
  • Table 29 : Global Market for Cardiac Rhythm Management, by Type, Through 2030
  • Table 30 : Different Types of ECG
  • Table 31 : ECG Products, by Type
  • Table 32 : Different Types of Echocardiographs
  • Table 33 : Echocardiograph, by Company
  • Table 34 : Global Market for Diagnostics and Monitoring, by Type, Through 2030
  • Table 35 : Ventricular Assist Device, by Company
  • Table 36 : Intra-Aortic Balloon Pump, by Company
  • Table 37 : Global Market for Cardiac Assist Devices, by Type, Through 2030
  • Table 38 : Global Market for Electrophysiology, by Type, Through 2030
  • Table 39 : Global Market for Other Vascular Surgery Devices, by Type, Through 2030
  • Table 40 : Global Market for Cardiovascular Devices, by End User, Through 2030
  • Table 41 : Global Market for Cardiovascular Devices, by Region, Through 2030
  • Table 42 : North American Market for Cardiovascular Devices, by Country, Through 2030
  • Table 43 : North American Market for Cardiovascular Devices, by Product, Through 2030
  • Table 44 : North American Market for Interventional Cardiology, by Type, Through 2030
  • Table 45 : North American Market for Cardiac Rhythm Management, by Type, Through 2030
  • Table 46 : North American Market for Diagnostics and Monitoring, by Type, Through 2030
  • Table 47 : North American Market for Cardiac Assist Devices, by Type, Through 2030
  • Table 48 : North American Market for Electrophysiology, by Type, Through 2030
  • Table 49 : North American Market for Other Vascular Surgery Devices, by Type, Through 2030
  • Table 50 : North American Market for Cardiovascular Devices, by End User, Through 2030
  • Table 51 : European Market for Cardiovascular Devices, by Country, Through 2030
  • Table 52 : European Market for Cardiovascular Devices, by Product, Through 2030
  • Table 53 : European Market for Interventional Cardiology, by Type, Through 2030
  • Table 54 : European Market for Cardiac Rhythm Management, by Type, Through 2030
  • Table 55 : European Market for Diagnostics and Monitoring, by Type, Through 2030
  • Table 56 : European Market for Cardiac Assist Devices, by Type, Through 2030
  • Table 57 : European Market for Electrophysiology, by Type, Through 2030
  • Table 58 : European Market for Other Vascular Surgery Devices, by Type, Through 2030
  • Table 59 : European Market for Cardiovascular Devices, by End User, Through 2030
  • Table 60 : Asia-Pacific Market for Cardiovascular Devices, by Country, Through 2030
  • Table 61 : Asia-Pacific Market for Cardiovascular Devices, by Product, Through 2030
  • Table 62 : Asia-Pacific Market for Interventional Cardiology, by Type, Through 2030
  • Table 63 : Asia-Pacific Market for Cardiac Rhythm Management, by Type, Through 2030
  • Table 64 : Asia-Pacific Market for Diagnostics and Monitoring, by Type, Through 2030
  • Table 65 : Asia-Pacific Market for Cardiac Assist Devices, by Type, Through 2030
  • Table 66 : Asia-Pacific Market for Electrophysiology, by Type, Through 2030
  • Table 67 : Asia-Pacific Market for Other Vascular Surgery Devices, by Type, Through 2030
  • Table 68 : Asia-Pacific Market for Cardiovascular Devices, by End User, Through 2030
  • Table 69 : South American Market for Cardiovascular Devices, by Product, Through 2030
  • Table 70 : South American Market for Interventional Cardiology, by Type, Through 2030
  • Table 71 : South American Market for Cardiac Rhythm Management, by Type, Through 2030
  • Table 72 : South American Market for Diagnostics and Monitoring, by Type, Through 2030
  • Table 73 : South American Market for Cardiac Assist Devices, by Type, Through 2030
  • Table 74 : South American Market for Electrophysiology, by Type, Through 2030
  • Table 75 : South American Market for Other Vascular Surgery Devices, by Type, Through 2030
  • Table 76 : South American Market for Cardiovascular Devices, by End User, Through 2030
  • Table 77 : MEA Market for Cardiovascular Devices, by Product, Through 2030
  • Table 78 : MEA Market for Interventional Cardiology, by Type, Through 2030
  • Table 79 : MEA Market for Cardiac Rhythm Management, by Type, Through 2030
  • Table 80 : MEA Market for Diagnostics and Monitoring, by Type, Through 2030
  • Table 81 : MEA Market for Cardiac Assist Devices, by Type, Through 2030
  • Table 82 : MEA Market for Electrophysiology, by Type, Through 2030
  • Table 83 : MEA Market for Other Vascular Surgery Devices, by Type, Through 2030
  • Table 84 : MEA Market for Cardiovascular Devices, by End User, Through 2030
  • Table 85 : Global Market Share Analysis for Cardiovascular Devices, by Company, 2024
  • Table 86 : Cardiovascular Devices: Recent Strategic Developments, 2024-2026
  • Table 87 : Report Information Sources
  • Table 88 : Abbreviations Used in the Cardiovascular Devices Market Report
  • Table 89 : Abbott: Company Snapshot
  • Table 90 : Abbott: Financial Performance, FY 2023 and 2024
  • Table 91 : Abbott: Product Portfolio
  • Table 92 : Abbott: News/Key Developments, 2023-2025
  • Table 93 : Baxter: Company Snapshot
  • Table 94 : Baxter: Financial Performance, FY 2023 and 2024
  • Table 95 : Baxter: Product Portfolio
  • Table 96 : B. Braun SE: Company Snapshot
  • Table 97 : B. Braun SE: Financial Performance, FY 2023 and 2024
  • Table 98 : B. Braun SE: Product Portfolio
  • Table 99 : Biotronik: Company Snapshot
  • Table 100 : Biotronik: Product Portfolio
  • Table 101 : Biotronik: News/Key Developments, 2023-2025
  • Table 102 : Boston Scientific Corp.: Company Snapshot
  • Table 103 : Boston Scientific Corp.: Financial Performance, FY 2023 and 2024
  • Table 104 : Boston Scientific Corp.: Product Portfolio
  • Table 105 : Boston Scientific Corp.: News/Key Developments, 2024-2026
  • Table 106 : BPL Medical Technologies: Company Snapshot
  • Table 107 : BPL Medical Technologies: Product Portfolio
  • Table 108 : Cook: Company Snapshot
  • Table 109 : Cook: Product Portfolio
  • Table 110 : Edwards Lifesciences Corp.: Company Snapshot
  • Table 111 : Edwards Lifesciences Corp.: Financial Performance, FY 2023 and 2024
  • Table 112 : Edwards Lifesciences Corp.: Product Portfolio
  • Table 113 : Edwards Lifesciences Corp.: News/Key Developments, 2024-2025
  • Table 114 : GE HealthCare: Company Snapshot
  • Table 115 : GE HealthCare: Financial Performance, FY 2023 and 2024
  • Table 116 : GE HealthCare: Product Portfolio
  • Table 117 : GE HealthCare: News/Key Developments, 2023
  • Table 118 : Johnson & Johnson: Company Snapshot
  • Table 119 : Johnson & Johnson: Financial Performance, FY 2023 and 2024
  • Table 120 : Johnson & Johnson: Product Portfolio
  • Table 121 : Johnson & Johnson: News/Key Developments, 2023-2025
  • Table 122 : Koninklijke Philips N.V.: Company Snapshot
  • Table 123 : Koninklijke Philips N.V.: Financial Performance, FY 2023 and 2024
  • Table 124 : Koninklijke Philips N.V.: Product Portfolio
  • Table 125 : Medtronic: Company Snapshot
  • Table 126 : Medtronic: Financial Performance, FY 2023 and 2024
  • Table 127 : Medtronic: Product Portfolio
  • Table 128 : Medtronic: News/Key Developments, 2023-2025
  • Table 129 : Nihon Kohden Corp.: Company Snapshot
  • Table 130 : Nihon Kohden Corp.: Financial Performance, FY 2023 and 2024
  • Table 131 : Nihon Kohden Corp.: Product Portfolio
  • Table 132 : Nihon Kohden Corp.: News/Key Developments, 2024
  • Table 133 : Siemens Healthineers AG: Company Snapshot
  • Table 134 : Siemens Healthineers AG: Financial Performance, FY 2023 and 2024
  • Table 135 : Siemens Healthineers AG: Product Portfolio
  • Table 136 : Siemens Healthineers AG: News/Key Developments, 2023
  • Table 137 : Terumo Corp.: Company Snapshot
  • Table 138 : Terumo Corp.: Financial Performance, FY 2023 and 2024
  • Table 139 : Terumo Corp.: Product Portfolio
  • Table 140 : Terumo Corp.: News/Key Developments, 2025
  • Table 141 : List of a Few Emerging Start-Ups/ Market Disruptors

List of Figures

  • Summary Figure : Global Market Shares of Cardiovascular Devices, by Region, 2024
  • Figure 1 : Heart Bypass Surgery Cost Structure, India, 2025
  • Figure 2 : Porter's Five Forces Analysis of the Technologies for Cardiovascular Devices Market
  • Figure 3 : Snapshot of Market Dynamics of Cardiovascular Devices
  • Figure 4 : Advantages of Minimally Invasive Procedures in Cardiovascular Treatment
  • Figure 5 : CARDIOLOGY: Remote Patient Monitoring Solutions
  • Figure 6 : Challenges in Cardiovascular Device Manufacturing
  • Figure 7 : Emerging Trends/Technologies in the Cardiovascular Devices Market
  • Figure 8 : Patents Granted, by Year, 2022-2025
  • Figure 9 : Global Market Shares of Cardiovascular Devices, by Product, 2024
  • Figure 10 : Global Market Shares of Cardiovascular Devices, by End User, 2024
  • Figure 11 : Global Market Shares of Cardiovascular Devices, by Region, 2024
  • Figure 12 : North American Market Shares of Cardiovascular Devices, by Country, 2024
  • Figure 13 : European Market Shares of Cardiovascular Devices, by Country, 2024
  • Figure 14 : Asia-Pacific Market Shares of Cardiovascular Devices, by Country, 2024
  • Figure 15 : Abbott: Revenue Shares, by Business Unit, FY 2024
  • Figure 16 : Abbott: Revenue Shares, by Country/Region, FY 2024
  • Figure 17 : Baxter: Revenue Shares, by Business Unit, FY 2024
  • Figure 18 : Baxter: Revenue Shares, by Country/Region, FY 2024
  • Figure 19 : B. Braun SE: Revenue Shares, by Business Unit, FY 2024
  • Figure 20 : B. Braun SE: Revenue Shares, by Country/Region, FY 2024
  • Figure 21 : Boston Scientific Corp.: Revenue Shares, by Business Unit, FY 2024
  • Figure 22 : Boston Scientific Corp.: Revenue Shares, by Country/Region, FY 2024
  • Figure 23 : Edwards Lifesciences Corp.: Revenue Shares, by Business Unit, FY 2024
  • Figure 24 : Edwards Lifesciences Corp.: Revenue Shares, by Country/Region, FY 2024
  • Figure 25 : GE HealthCare: Revenue Shares, by Business Unit, FY 2024
  • Figure 26 : GE HealthCare: Revenue Shares, by Country/Region, FY 2024
  • Figure 27 : Johnson & Johnson: Revenue Shares, by Business Segment, FY 2024
  • Figure 28 : Johnson & Johnson: Revenue Shares, by Country/Region, FY 2024
  • Figure 29 : Koninklijke Philips N.V.: Revenue Shares, by Business Unit, FY 2024
  • Figure 30 : Koninklijke Philips N.V.: Revenue Shares, by Country/Region, FY 2024
  • Figure 31 : Medtronic: Revenue Shares, by Business Unit, FY 2024
  • Figure 32 : Medtronic: Revenue Shares, by Region/Country, FY 2024
  • Figure 33 : Nihon Kohden Corp.: Revenue Shares, by Business Unit, FY 2024
  • Figure 34 : Nihon Kohden Corp.: Revenue Shares, by Region/Country, FY 2024
  • Figure 35 : Siemens Healthineers AG: Revenue Shares, by Business Unit, FY 2024
  • Figure 36 : Siemens Healthineers AG: Revenue Shares, by Country/Region, FY 2024
  • Figure 37 : Terumo Corp.: Revenue Shares, by Business Unit, FY 2024
  • Figure 38 : Terumo Corp.: Revenue Shares, by Country/Region, FY 2024
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!